BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cipla
Daiichi Sankyo
Covington
Federal Trade Commission
Mallinckrodt
Julphar
Boehringer Ingelheim
Cerilliant
Dow

Generated: January 23, 2018

DrugPatentWatch Database Preview

TRIMETHOPRIM Drug Profile

« Back to Dashboard

Which patents cover Trimethoprim, and when can generic versions of Trimethoprim launch?

Trimethoprim is a drug marketed by Mayne Pharma, Novel Labs Inc, Sun Pharm Industries, Teva, Watson Labs, Akorn Inc, Bausch And Lomb, and Sandoz Inc. and is included in nine NDAs.

The generic ingredient in TRIMETHOPRIM is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.

US Patents and Regulatory Information for TRIMETHOPRIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma TRIMETHOPRIM trimethoprim TABLET;ORAL 018679-001 Jul 30, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn Inc TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 065006-001 Dec 17, 1998 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries TRIMETHOPRIM trimethoprim TABLET;ORAL 070495-001 Sep 24, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064120-001 Feb 14, 1997 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novel Labs Inc TRIMETHOPRIM trimethoprim TABLET;ORAL 091437-001 Jun 15, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries TRIMETHOPRIM trimethoprim TABLET;ORAL 070494-001 Jan 22, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs TRIMETHOPRIM trimethoprim TABLET;ORAL 070049-001 Jun 6, 1985 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva TRIMETHOPRIM trimethoprim TABLET;ORAL 071259-001 Jun 18, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064211-001 Apr 13, 1998 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Mallinckrodt
Queensland Health
Healthtrust
McKesson
Cipla
Deloitte
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot